Sodium lauryl ether sulfo-succinate 6% / Sodium lauryl ether sulfate 2.7% shampoo
Available from pharmacies, supermarkets, and retail outlets
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Sodium lauryl ether sulfo-succinate + Sodium lauryl ether sulfate
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
3 branded products available
MHRA licensed products
View all licensed products for Sodium lauryl ether sulfo-succinate + Sodium lauryl ether sulfate on the MHRA register
Dentinox Cradle Cap treatment shampoo
Sodium lauryl ether sulfo-succinate 6% / Sodium lauryl ether sulfate 2.7% shampoo
Sodium lauryl ether sulfo-succinate 6% / Sodium lauryl ether sulfate 2.7% shampoo
This is the NHS Drug Tariff indicative price used for reimbursement purposes. It may not reflect the price paid by patients or pharmacies.
View full Drug TariffSource: NHS Drug Tariff via NHSBSA. Derived from dm+d VMPP (Virtual Medicinal Product Pack) pricing data. Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
1983–2026
Showing the 50 most relevant studies, sorted by most relevant.
Jelena Milinković Budinčić, Lidija Petrović, Ljiljana Đekić, et al.
Carbohydrate Polymers, 2021
Shuli Li, Shuduan Deng, Dake Xu, et al.
Corrosion Science, 2024
Rachel L. Hendrikse, Andrew E. Bayly, Peter K. Jimack, et al.
The Journal of Physical Chemistry B, 2023
Rosalia Ferraro, Maria Michela Salvatore, Rodolfo Esposito, et al.
Journal of Molecular Liquids, 2024
E. Yücel
Acta Physica Polonica A, 2023
Hussein Ali Awadh AL-Zamili, Ithar Kamil Al-Mayaly
Journal of Degraded and Mining Lands Management, 2024
Sodium lauryl ether sulfate (SLES) is a surfactant commonly used in the formulation of detergents, which is typically disposed of in wastewater treatment plants. The current study describes the effectiveness of bacteria isolated from Iraqi wastewater to remove SLES. 16S rRNA genetic analysis revealed that this strain is Pseudomonas aeruginosa. Three temperatures (30, 35, and 40oC) and pH values (5,7, and 9) were chosen for this study, and three concentrations of SLES (25, 50, and 100 mg/L) were used. The SLES anionic surfactant showed that the best biodegradation by Pseudomonas aeruginosa was at a temperature of 30oC and both pH 7 and 9, while the removal percentages for them were 98.44% and 96.36%, respectively, at 25 mg/L of SLES. The outcomes of this study revealed the potential and significance of SLES removal in actual effluents by aerobic biodegradation. The ability of this bacterium to degrade SLES makes the bacterium an important tool for bioremediation.
Abstract licence: CC BY-NC 4.0
Ericson Mata‐Zabala, Luz Margarita Rattia Bravo, Álvaro Javier Patiño‐Agudelo, et al.
Journal of Surfactants and Detergents, 2025
H. Löffler, R. Happle
Contact Dermatitis, 2003
Hussein Ali Awadh Al-Zamili, Ithar Kamil Al-Mayaly
Iraqi Journal of Science, 2025
Sodium lauryl ether sulfate (SLES), a surfactant frequently incorporated into detergent formulations, typically ends up in wastewater treatment facilities after use. The present study aims to investigate the efficacy of bacteria isolated from Iraqi wastewater in removing SLES. Genetic analysis (16S rRNA) revealed that this strain is Klebsiella oxytoca. Three temperatures (30, 35 and 40) oC and pH values (5,7 and 9) were selected for this study, and three concentrations of SLES (25, 50, 100) mg/l were used. The SLES anionic surfactant demonstrated that the best biodegradation by Klebsiella oxytoca occurred at 30 oC and both pH 7 and 9, while the removal percentage for them was 98.32% and 95.4 %, respectively at 25 mg/l of SLES. The outcomes of this study revealed the potential and significance of SLES removal in actual effluents by aerobic biodegradation. The ability of this bacterium to degrade SLES makes it an important tool for bioremediation.
Abstract licence: CC BY-NC 4.0
Harshita Budhadev
International Journal of Research Publication and Reviews, 2024
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.